Prelude Capital Management, LLC Neogenomics Inc Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$18.96 - $29.84 $53,277 - $83,850
-2,810 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$19.12 - $26.24 $53,727 - $73,734
2,810 New
2,810 $54,000
Q1 2019

May 15, 2019
SELL
$12.14 - $20.46 $4,904 - $8,265
-404 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$11.24 - $18.5 $4,540 - $7,474
404 New
404 $5,000

Others Institutions Holding NEO

# of Institutions
278
Shares Held
127M
Call Options Held
581K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email